SHARON FELDMAN: Open Payments
NPI 1750534376 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 18 payments from 9 companies in 2025. Trend: 2023 $581 · 2024 $691 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $172 |
| ABBVIE INC. | 2 | $161 |
| Merck Sharp & Dohme LLC | 2 | $50 |
| SOBI, INC | 1 | $43 |
| Gilead Sciences, Inc. | 1 | $34 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| Myriad Genetic Laboratories, Inc. | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Ethicon US, LLC | 1 | $15 |
Products named: LYNPARZA, ELAHERE, Vonjo, Trodelvy, KEYTRUDA, JEMPERLI, MYRISK, LIBTAYO.
Industry payments across TX — which companies pay providers there.
